Angel Matthew bought TPST
February 4, 2026 · Form 4 insider transaction
Angel Matthew bought 269,621 shares of Tempest Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
269,621
Price
$0.00
Total value
N/A
InsiderAngel Matthew
RoleOfficer, Director, 10% owner
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateFebruary 4, 2026
Filing dateFebruary 6, 2026
Shares owned after269,621
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option shall vest with respect to 25% of the total number of shares underlying the option on February 4, 2027 and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service.